Wearable ECG Monitor to check on your heart
October 16, 2018
Source: drugdu
332
The Medical-level ECG recorder to monitor cardiac risk in sport, manufactured and supplied by the Chinese firm, Jiangxi Yeeroo Industrial Co., Ltd, is made available on Ddu (Drugdu.com), the leading global pharmaceutical and medical devices online B2B platform.
This ECG monitor works on the HeartBook MCT which is a multi-parameter cardiac telemetry system. It helps you stay connected with your health by Minttihealth ECG. It is the easiest and sleekest ECG reading wearable medical device available in the market. It is a known and trusted product world over. It gives modern-design ECG of excellent quality and provides top service.
The ECG monitor’s sleek and compact design enables you to know your heart’s health anytime, anywhere while it sits in your pocket. It has an in-built real-time monitor of multi-parameters, like the body posture sensor. It is built in an ergonomic design. It has an additional alarm feature which gives a real-time alert on APB, VPB, long interval, tachycardia, and bradycardia or when a tumble-down occurs, it sends SMS alerts to the guardian’s phone. It gets you connected immediately with medical professionals who give conclusions to the parameters recorded.
Copyright©2024 Ddu. All rights reserved.
Read more on
- Cornerstone Pharmaceuticals has reached a strategic cooperation on anti-PD-L1 monoclonal antibodies in the Middle East and Africa regions November 22, 2024
- Hand in hand with Merck and acquire shares from Zhongsheng Pharmaceutical! Lixin Pharmaceutical has become a dark horse in the development of new drugs, with a total pipeline BD transaction volume exceeding 28 billion yuan November 22, 2024
- Junshi Biotechnology introduces two cancer dual target fusion protein drugs November 22, 2024
- China Biopharmaceuticals announces signing equity investment and strategic cooperation agreement with Lixin Pharmaceutical November 22, 2024
- As the industry is going down, more and more pharmaceutical companies are seeking to “exit”? November 22, 2024
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
